BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15094213)

  • 1. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
    Lu Y; Sega E; Leamon CP; Low PS
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1161-76. PubMed ID: 15094213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors.
    Lu Y; Low PS
    Cancer Immunol Immunother; 2002 May; 51(3):153-62. PubMed ID: 11941454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
    Sega EI; Lu Y; Ringor M; Leamon CP; Low PS
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):559-66. PubMed ID: 18411004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential.
    Lu Y; You F; Vlahov I; Westrick E; Fan M; Low PS; Leamon CP
    Mol Pharm; 2007; 4(5):695-706. PubMed ID: 17784727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor detection using folate receptor-targeted imaging agents.
    Sega EI; Low PS
    Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.
    Figini M; Martin F; Ferri R; Luison E; Ripamonti E; Zacchetti A; Mortarino M; Di Cioccio V; Maurizi G; Allegretti M; Canevari S
    Cancer Immunol Immunother; 2009 Apr; 58(4):531-46. PubMed ID: 18704410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
    Paulos CM; Reddy JA; Leamon CP; Turk MJ; Low PS
    Mol Pharmacol; 2004 Dec; 66(6):1406-14. PubMed ID: 15371560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-mediated targeting of T cells to tumors.
    Roy EJ; Gawlick U; Orr BA; Kranz DM
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1219-31. PubMed ID: 15094217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
    Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
    Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-targeted chemotherapy.
    Leamon CP; Reddy JA
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-targeted non-viral DNA vectors for cancer gene therapy.
    Ward CM
    Curr Opin Mol Ther; 2000 Apr; 2(2):182-7. PubMed ID: 11249640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates.
    Reddy JA; Westrick E; Vlahov I; Howard SJ; Santhapuram HK; Leamon CP
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):229-36. PubMed ID: 16331500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapies to improve tumor immunotherapy.
    Begley J; Ribas A
    Clin Cancer Res; 2008 Jul; 14(14):4385-91. PubMed ID: 18628452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
    Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
    J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Folate receptor-mediated antitumor drugs].
    Zhao J; Cao SL; Zheng XL; Zhao B
    Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
    Reddy JA; Westrick E; Santhapuram HK; Howard SJ; Miller ML; Vetzel M; Vlahov I; Chari RV; Goldmacher VS; Leamon CP
    Cancer Res; 2007 Jul; 67(13):6376-82. PubMed ID: 17616697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-targeted drug strategies for the treatment of cancer.
    Leamon CP
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1277-86. PubMed ID: 19037834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells.
    Lu Y; Sega E; Low PS
    Int J Cancer; 2005 Sep; 116(5):710-9. PubMed ID: 15828051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.